None listed
Conditions
Interventions
Others : The intervention is whether the neurotization using acellular nerve graft is applied to the subjects during breast reconstruction.
The experimental group will receive the breast reconstructi
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: From twenty to sixty-nine years old female breast cancer patients who shall receive the breast reconstruction and are voluntarily willing to participate the study with the understanding of the purpose of this study.
Exclusion criteria
Exclusion criteria: 1) A person who has used drugs that may affect the effectiveness evaluation at the discretion of the researcher, such as immunosuppressants, antithrombotic agents, steroids, etc., within two weeks from the date of the screening visit. 2) Individuals whose mental state may affect the performance of the clinical trial due to alcohol or drug abuse. 3) Individuals who are unable to complete the surveys conducted in this clinical study. 4) Individuals who have participated in another clinical trial within 120 days prior to screening. (except when the investigator determines that participation in the other clinical trial does not affect this study). 5) Individuals who have a surgical history including breast augmentation, tumor excision, and breast-conserving surgery in the breast reconstruction area. 6) Other cases where the investigator determines that the participant is not suitable for this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of the breast sensory recovery in accordance with the Semmes-Weinstein monofilament test | — |
Secondary
| Measure | Time frame |
|---|---|
| Subject's self-assessment of satisfaction after breast reconstruction by the Breast-Q reconstruction module(survey) | — |
Countries
Korea, Republic of
Contacts
Public ContactHyun Ho Han
Asan Medical Center
Outcome results
None listed